Europe OTC Parasiticides Market size is anticipated to cross USD 634.89 Million by the end of 2031, witnessing around 6.26% CAGR during the forecast period, i.e., 2022-2031. In the year 2021, the industry size of europe OTC parasiticides was USD 347.42 Million. The growth of the market can be attributed to the eruption of various diseases caused by bacteria, fungi and parasites among animals, which in turn can risk human health as well. According to the most recent information from the joint EFSA, ECDC, and EU reference laboratory study, there have been around 3,500 HPAI (Highly Pathogenic Avian Influenza) occurrences in wild birds and nearly 2,400 outbreaks in poultry, with about 48 million birds being killed in the affected premises.
In addition to these, factors that are believed to fuel the growth of the Europe OTC parasiticide market include the rising affection of people towards animals is increasing the number of pets in households. There is more physical interaction between humans and pets, which can also affect human health if their pet is suffering from parasite infestation. which is expected to boost the growth of Europe OTC parasiticides market. In the European Union, around 90 million households own a pet, which makes up almost 46% of households. Furthermore, increasing the risk of humans getting infected by parasitic worms. In 2021, the IPI prevalence rate in children is approximately 6%. Moreover, Blastocystis hominis parasite have the highest pervasion rate of 11% in the European countries.
Growth Drivers
Rising Demand for Parasiticides- With the growing number of diseases among animals which can be caused by various organisms such as bacteria, parasites, and viruses. The demand for parasiticides is also boosting. Out of the total sale of animal healthcare products in Europe, parasiticides held a share of approximately 30% in the year 2021.
Higher Adoption of Pets- Pets may contract ordinary parasites like fleas or particularly harmful ones like heartworms. Pet dogs and cats are frequently exposed to a variety of internal and external parasites. In the European Union, nearly 84 million cats were kept as pets followed by around 73 million dogs. Moreover, the count of ornamental bird and other small mammals were about 34 million and 22 million, respectively.
Acquisition and Collaboration Among the Prominent Company- In June 2022, Orion Animal Health partnered with Inovet. The combined company expands its global reach and product offerings to include both livestock and companion animals, making it a significant player in the animal health industry.
Higher Number of People Offering Veterinary Services in Europe- In Europe, there are more than 214,000 people working in veterinary services. More than 70,000 businesses make up the Veterinary Service. Veterinarians can help people to understand the effective use of parasiticides for an animal that is infested with fleas or ticks, which in turn is expected to boost the sales of OTC parasiticides.
Increased Population of Cattle- Few parasites, such as endoparasiticides can be transferred to humans by consuming animal-derived food. The cattle should be treated with parasiticides in order to prevent the transmission of parasites. In December 2019, there were 62 million sheep, 12 million goats, 77 million bovine animals, and 143 million pigs in the EU. Moreover, the total number of dairy cows older than 12 months in the UK was around 3 million head as of June 2021.
Challenges
|
Base Year |
2021 |
|
Forecast Year |
2022-2031 |
|
CAGR |
6.26% |
|
Base Year Market Size (2021) |
USD 347.42 Million |
|
Forecast Year Market Size (2031) |
USD 634.89 Million |
|
Regional Scope |
|
Animals (Dogs, Cats)
The Europe OTC parasiticides market is segmented and analyzed for demand and supply by animals into dogs, cats, and others. Out of the three types of animals, the dogs segment is anticipated to hold the largest market size of USD 286.02 million by the end of 2031 by growing at a CAGR of 6.47% over the forecast period. The segment garnered a revenue of USD 153.46 million in 2021. The growth of the segment can be attributed to the higher number of dogs present in Europe. With more than nearly 10 million dogs as pets, Germany had the greatest pet dog population in the EU in 2021. Spain came in second place with around 9 million dogs. There were roughly 660,000 and 610,000 dogs living in the populations of other nations, such as Greece and Denmark.
Product Type (Ectoparasiticides, Endoparasiticides, Endectocides)
The Europe OTC parasiticides market is also segmented and analyzed for demand and supply by product type into ectoparasiticides, endoparasiticides, and endectocides. Amongst these three segments, the ectoparasiticides segment is expected to garner a market revenue of USD 292.35 million at the end of 2031 by growing at a CAGR of 6.33% over the projected time frame. The segment generated a revenue of USD 158.97 million by 2021. Ectoparasiticides are used to control ticks, mites, flies, and fleas. The medicines for flea and tick infestation are readily available in pharmacies and supermarkets, pet owners can access the medicines without any mandatory prescription from a doctor. flea and tick infestation in dogs and cats is a serious health issue. Moreover, they can occur on healthy animals and they usually attack the injured area of the animal. Therefore, segment growth can be expected on the account of the rising number of dogs that are injured in conflict with other animals, injuries caused by a natural disaster, or accidental injuries. On European roadways, an estimated 29 million animals and 194 million birds per year are thought to be killed. Furthermore, ectoparasiticides is further categorized into pour on, spot on, sprays, and others.
Our in-depth analysis of the global market includes the following segments:
|
By Product |
|
|
By Animal |
|
|
By End User |
|
|
By Distribution Channel |
|
The Europe OTC parasiticides market is segmented into Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Poland, Portugal, Spain, and Rest of Europe (EU 27). Amongst all, the Rest of Europe market in all the other regions is projected to hold the largest market share of USD 180.1 million by the end of 2031. The market in the region is to display growth at a CAGR of 5.59% over the forecast period. In 2021, the region garnered a revenue of USD 104.90 million. The growth of the market can be attributed majorly to the higher number of vets present across the several countries in the region followed by increased expenditure on pet care. A higher number of vets can help people to prescribe the best solution for the parasite-infected area and create awareness about parasiticides among pet owners or social workers. There are nearly 29,000 vets in the United Kingdom. Moreover, nearly USD 6 billion is spent annually on veterinary services by UK pet owners. Additionally, there are more than 12 million households and around 50 million pet owners in the United States. Cats are the second most popular pet after dogs.
Merck & Co., Inc., announced the acquisition of Vecoxan, the leading brand of parasiticides for ruminant line. Through this acquisition, Merck Animal Health is to improve parasite protection for calves and lambs, expanding its market position.
Chanelle Pharma, announced the completion of documentation of new Bisoprolol. For those with heart failure, hypertension, and angina, bisoprolol is regarded as a crucial therapeutic choice.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?